Center of Neurodegeneration, Faculty of Medicine/Dental Medicine, Danube Private University, Krems, Austria; Institut de Psychiatrie et Neurosciences de Paris (IPNP), UMR S1266, INSERM, Université de Paris, Paris, France; GHU Psychiatrie et Neurosciences, Paris, France.
Department of Physics and Chemistry of Materials, Faculty of Medicine/Dental Medicine, Danube Private University, Krems, Austria.
Am J Otolaryngol. 2021 Sep-Oct;42(5):103014. doi: 10.1016/j.amjoto.2021.103014. Epub 2021 Apr 13.
Smell dysfunction has been recognized as an early symptom of SARS-CoV-2 infection, often occurring before the onset of core symptoms of the respiratory tract, fever or muscle pain. In most cases, olfactory dysfunction is accompanied by reduced sense of taste, is partial (microsmia) and seems to normalize after several weeks, however, especially in cases of virus-induced complete smell loss (anosmia), there are indications of persisting deficits even 2 months after recovery from the acute disease, pointing towards the possibility of chronic or even permanent smell reduction for a significant part of the patient population. To date, we have no knowledge on the specificity of anosmia towards specific odorants or chemicals and about the longer-term timeline of its persistence or reversal.
In this longitudinal study, 70 participants from a community in Lower Austria that had been tested positive for either IgG or IgM SARS-CoV-2 titers in June 2020 and a healthy control cohort (N = 348) underwent smell testing with a 12-item Cross-Cultural Smell Identification Test (CC-SIT), based upon items from the University of Pennsylvania Smell Identification Test (UPSIT). The test was performed in October 2020, i.e. 4 months after initial diagnosis via antibody testing. Results were analyzed using statistical tests for contingency for each smell individually in order to detect whether reacquisition of smell is dependent on specific odorant types.
For all odorants tested, except the odor "smoke", even 4 months or more after acute SARS-CoV-2 infection, participants with a positive antibody titer had a reduced sense of smell when compared to the control group. On average, while the control cohort detected a set of 12 different smells with 88.0% accuracy, the antibody-positive group detected 80.0% of tested odorants. A reduction of accuracy of detection by 9.1% in the antibody-positive cohort was detected. Recovery of the ability to smell was particularly delayed for three odorants: strawberry (encoded by the aldehyde ethylmethylphenylglycidate), lemon (encoded by citronellal, a monoterpenoid aldehyde), and soap (alkali metal salts of the fatty acids plus odorous additives) exhibit a sensitivity of detection of an infection with SARS-CoV-2 of 31.0%, 41.0% and 40.0%, respectively.
Four months or more after acute infection, smell performance of SARS-CoV-2 positive patients with mild or no symptoms is not fully recovered, whereby the ability to detect certain odors (strawberry, lemon and soap) is particularly affected, suggesting the possibility that these sensitivity to these smells may not only be lagging behind but may be more permanently affected.
嗅觉功能障碍已被认为是 SARS-CoV-2 感染的早期症状,通常发生在呼吸道核心症状(发热或肌肉疼痛)出现之前。在大多数情况下,嗅觉功能障碍伴有味觉减退,是局部的(嗅觉减退),并且似乎在数周后恢复正常,然而,特别是在病毒引起的完全嗅觉丧失(嗅觉丧失)的情况下,即使在从急性疾病中康复后 2 个月,仍有持续存在缺陷的迹象,这表明对相当一部分患者人群来说,嗅觉可能会出现慢性甚至永久性的降低。迄今为止,我们对特定气味剂或化学物质的嗅觉丧失的特异性以及其持续时间或逆转的长期时间线知之甚少。
在这项纵向研究中,2020 年 6 月对奥地利下奥地利州的一个社区进行了 IgG 或 IgM SARS-CoV-2 滴度检测呈阳性的 70 名参与者和一个健康对照组(N=348)进行了嗅觉测试,使用了 12 项跨文化嗅觉识别测试(CC-SIT),该测试基于宾夕法尼亚大学嗅觉识别测试(UPSIT)的项目。测试于 2020 年 10 月进行,即在通过抗体测试最初诊断后 4 个月。对每个单独的气味进行了用于连续事件的统计测试,以检测嗅觉的重新获得是否取决于特定的气味类型。
对于所有测试的气味剂,除了“烟雾”气味外,即使在急性 SARS-CoV-2 感染后 4 个月或更长时间,抗体阳性者的嗅觉也比对照组差。平均而言,虽然对照组以 88.0%的准确率检测到一组 12 种不同的气味,但抗体阳性组检测到 80.0%的测试气味剂。在抗体阳性组中,检测准确性降低了 9.1%。对于三种气味剂(编码为醛乙基甲基苯基缩水甘油酸的草莓、编码为柠檬醛的柠檬、编码为脂肪酸的碱金属盐和有气味添加剂的肥皂),嗅觉恢复尤其延迟,对 SARS-CoV-2 感染的检测敏感性分别为 31.0%、41.0%和 40.0%。
急性感染后 4 个月或更长时间,症状轻微或无症状的 SARS-CoV-2 阳性患者的嗅觉表现并未完全恢复,其中对某些气味(草莓、柠檬和肥皂)的检测能力特别受到影响,这表明这些气味的敏感性可能不仅滞后,而且可能受到更持久的影响。